Merrion Investment Management’s Pfizer PFE Stock Holding History

Merrion Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,816	Closed	-$213K	–	102
2023 Q2	$213K	Hold	5,816	–	–	0.18%	94
2023 Q1	$237K	Hold	5,816	–	–	0.23%	81
2022 Q4	$298K	Hold	5,816	–	–	0.28%	65
2022 Q3	$254K	Hold	5,816	–	–	0.25%	73
2022 Q2	$305K	Hold	5,816	–	–	0.3%	67
2022 Q1	$301K	Sell	5,816 -300	-5%	-$15.6K	0.22%	79
2021 Q4	$361K	Buy	6,116 +1,050	+21%	+$52K	0.26%	71
2021 Q3	$217K	Buy	+5,066	New	+$224K	0.17%	88
2021 Q1	–	Sell	-816	Closed	-$30K	–	194
2020 Q4	$30K	Buy	+816	New	+$29.9K	0.03%	144

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Merrion Investment Management's PFE Position: Q3 2023 in Review

Merrion Investment Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,816 shares — an estimated $213K sold.

Merrion Investment Management first reported a position in PFE in Q4 2020 and held it in 9 quarters. The position peaked at $361K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Merrion Investment Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Merrion Investment Management sold 5,816 Pfizer shares in Q3 2023, an estimated $213K.
Merrion Investment Management first reported a position in Pfizer in Q4 2020 and held it in 9 quarters.
Merrion Investment Management's Pfizer position peaked at $361K in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Merrion Investment Management's 13F filing for Q3 2023, filed 19 Oct 2023.